These observations suggest that the inflammasome pathway and its downstream mediators, such as IL-1β and NETosis, may be effective therapeutic targets and could be downmodulated by hypothermia during management of ARDS. This evidence concerns the gene IL1B and acute respiratory distress syndrome.